nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ORM1—bile—sclerosing cholangitis	0.142	0.212	CbGeAlD
Erlotinib—SLCO2B1—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0452	0.137	CbGpPWpGaD
Erlotinib—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0397	0.12	CbGpPWpGaD
Erlotinib—ORM1—gall bladder—sclerosing cholangitis	0.0393	0.0588	CbGeAlD
Erlotinib—NR1I2—liver—sclerosing cholangitis	0.0377	0.0564	CbGeAlD
Erlotinib—ALB—gall bladder—sclerosing cholangitis	0.0345	0.0515	CbGeAlD
Erlotinib—PIP4K2C—pancreas—sclerosing cholangitis	0.0338	0.0505	CbGeAlD
Erlotinib—SLK—pancreas—sclerosing cholangitis	0.0287	0.043	CbGeAlD
Erlotinib—TNK1—liver—sclerosing cholangitis	0.0277	0.0414	CbGeAlD
Erlotinib—FLT3—liver—sclerosing cholangitis	0.0238	0.0356	CbGeAlD
Erlotinib—ABL2—liver—sclerosing cholangitis	0.0227	0.0339	CbGeAlD
Erlotinib—EGFR—liver—sclerosing cholangitis	0.0222	0.0331	CbGeAlD
Erlotinib—PIP4K2C—liver—sclerosing cholangitis	0.0215	0.0321	CbGeAlD
Erlotinib—ULK3—liver—sclerosing cholangitis	0.0205	0.0307	CbGeAlD
Erlotinib—MKNK1—liver—sclerosing cholangitis	0.0193	0.0289	CbGeAlD
Erlotinib—SLK—liver—sclerosing cholangitis	0.0183	0.0273	CbGeAlD
Erlotinib—ABL1—pancreas—sclerosing cholangitis	0.0172	0.0257	CbGeAlD
Erlotinib—STK10—liver—sclerosing cholangitis	0.0159	0.0238	CbGeAlD
Erlotinib—UGT1A1—liver—sclerosing cholangitis	0.015	0.0224	CbGeAlD
Erlotinib—MAP2K5—liver—sclerosing cholangitis	0.0142	0.0212	CbGeAlD
Erlotinib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.0126	0.0382	CbGpPWpGaD
Erlotinib—EGFR—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0125	0.0379	CbGpPWpGaD
Erlotinib—ORM1—liver—sclerosing cholangitis	0.0115	0.0172	CbGeAlD
Erlotinib—MKNK1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.0113	0.0343	CbGpPWpGaD
Erlotinib—SLCO2B1—liver—sclerosing cholangitis	0.0111	0.0165	CbGeAlD
Erlotinib—ABL1—liver—sclerosing cholangitis	0.011	0.0164	CbGeAlD
Erlotinib—ALB—liver—sclerosing cholangitis	0.0101	0.0151	CbGeAlD
Erlotinib—CYP3A5—pancreas—sclerosing cholangitis	0.0101	0.0151	CbGeAlD
Erlotinib—CYP1B1—liver—sclerosing cholangitis	0.00928	0.0139	CbGeAlD
Erlotinib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0089	0.0269	CbGpPWpGaD
Erlotinib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.008	0.0242	CbGpPWpGaD
Erlotinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00745	0.0225	CbGpPWpGaD
Erlotinib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00731	0.0221	CbGpPWpGaD
Erlotinib—CYP2C8—liver—sclerosing cholangitis	0.00711	0.0106	CbGeAlD
Erlotinib—ABCG2—liver—sclerosing cholangitis	0.00691	0.0103	CbGeAlD
Erlotinib—EGFR—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00684	0.0207	CbGpPWpGaD
Erlotinib—CYP1A2—liver—sclerosing cholangitis	0.00665	0.00994	CbGeAlD
Erlotinib—CYP1A1—liver—sclerosing cholangitis	0.00656	0.0098	CbGeAlD
Erlotinib—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00645	0.0195	CbGpPWpGaD
Erlotinib—CYP3A5—liver—sclerosing cholangitis	0.00641	0.00959	CbGeAlD
Erlotinib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00595	0.018	CbGpPWpGaD
Erlotinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.0059	0.0178	CbGpPWpGaD
Erlotinib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00581	0.0176	CbGpPWpGaD
Erlotinib—JAK3—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00573	0.0173	CbGpPWpGaD
Erlotinib—ABCB1—pancreas—sclerosing cholangitis	0.00536	0.008	CbGeAlD
Erlotinib—EGFR—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00514	0.0155	CbGpPWpGaD
Erlotinib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00513	0.0155	CbGpPWpGaD
Erlotinib—CYP3A4—liver—sclerosing cholangitis	0.00481	0.00719	CbGeAlD
Erlotinib—CYP2D6—liver—sclerosing cholangitis	0.00474	0.00708	CbGeAlD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00462	0.014	CbGpPWpGaD
Erlotinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00459	0.0139	CbGpPWpGaD
Erlotinib—CYP1B1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00456	0.0138	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00456	0.0138	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00395	0.0119	CbGpPWpGaD
Erlotinib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00388	0.0117	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.0037	0.0112	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00365	0.011	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00357	0.0108	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00354	0.0107	CbGpPWpGaD
Erlotinib—ABCB1—liver—sclerosing cholangitis	0.00341	0.00509	CbGeAlD
Erlotinib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00336	0.0101	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TCF4—sclerosing cholangitis	0.00312	0.00944	CbGpPWpGaD
Erlotinib—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00311	0.0094	CbGpPWpGaD
Erlotinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.003	0.00906	CbGpPWpGaD
Erlotinib—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00281	0.00849	CbGpPWpGaD
Erlotinib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00258	0.00778	CbGpPWpGaD
Erlotinib—EGFR—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00248	0.00749	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00246	0.00743	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00231	0.00699	CbGpPWpGaD
Erlotinib—EGFR—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00225	0.00681	CbGpPWpGaD
Erlotinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00223	0.00673	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0021	0.00636	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00208	0.00627	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00199	0.00602	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00182	0.0055	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0018	0.00544	CbGpPWpGaD
Erlotinib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00179	0.00541	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00172	0.0052	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—GGT1—sclerosing cholangitis	0.0017	0.00513	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00163	0.00492	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00159	0.0048	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00142	0.00428	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.00131	0.00395	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00125	0.00378	CbGpPWpGaD
Erlotinib—MKNK1—Disease—GOT2—sclerosing cholangitis	0.00119	0.00359	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00117	0.00355	CbGpPWpGaD
Erlotinib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.00114	0.00344	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00114	0.00344	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TCF4—sclerosing cholangitis	0.00112	0.00338	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.00111	0.00334	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00106	0.00321	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00105	0.00316	CbGpPWpGaD
Erlotinib—MKNK1—Disease—GOT1—sclerosing cholangitis	0.00102	0.0031	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—NOS2—sclerosing cholangitis	0.00101	0.00305	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000979	0.00296	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.000958	0.0029	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00093	0.00281	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000898	0.00271	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000892	0.0027	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000885	0.00267	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000787	0.00238	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000759	0.00229	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000721	0.00218	CbGpPWpGaD
Erlotinib—MKNK1—Disease—HIF1A—sclerosing cholangitis	0.000712	0.00215	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000708	0.00214	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000667	0.00201	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000652	0.00197	CbGpPWpGaD
Erlotinib—MKNK1—Disease—NOS2—sclerosing cholangitis	0.000648	0.00196	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000644	0.00195	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000624	0.00189	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000517	0.00156	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000514	0.00155	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000499	0.00151	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.000461	0.00139	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000436	0.00132	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000401	0.00121	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.0004	0.00121	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.000397	0.0012	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT2—sclerosing cholangitis	0.000391	0.00118	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000387	0.00117	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000376	0.00114	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000368	0.00111	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000366	0.00111	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	0.000361	0.00109	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000348	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT1—sclerosing cholangitis	0.000338	0.00102	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT2—sclerosing cholangitis	0.000336	0.00102	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000328	0.000992	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000311	0.000941	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000311	0.000941	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000307	0.000927	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000306	0.000925	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GGT1—sclerosing cholangitis	0.00029	0.000877	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT1—sclerosing cholangitis	0.00029	0.000877	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000278	0.00084	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000264	0.000798	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000264	0.000798	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000256	0.000774	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000254	0.000769	CbGpPWpGaD
Erlotinib—EGFR—Disease—HIF1A—sclerosing cholangitis	0.000235	0.00071	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000219	0.000663	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000215	0.000648	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—sclerosing cholangitis	0.000214	0.000646	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000207	0.000626	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.00019	0.000574	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	0.000189	0.000572	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	0.000189	0.000572	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000189	0.000571	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	0.000179	0.00054	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	0.000179	0.00054	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000165	0.0005	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000165	0.000497	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000164	0.000495	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000164	0.000495	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000163	0.000493	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000163	0.000493	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000156	0.000471	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000143	0.000432	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000143	0.000432	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000135	0.000407	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000135	0.000407	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000132	0.000399	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	0.000114	0.000345	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	0.000114	0.000345	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000102	0.000308	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	8.8e-05	0.000266	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	8.8e-05	0.000266	CbGpPWpGaD
